Results for Anxiety Disorders

Adolescent BPA exposure below the safe daily limit leads to alterations in some behaviours and neuronal morphology that endure into adulthood.

Article Published Date : Feb 28, 2015
Study Type : Animal Study
Additional Links
Diseases : Anxiety Disorders : CK(1558) : AC(241), Bisphenol Toxicity : CK(4416) : AC(1329)
Additional Keywords : Anxiety Disorders, Bisphenol A, Bisphenol Toxicity
Problem Substances : Bisphenol A : CK(4570) : AC(1323)

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety.

Article Published Date : Nov 14, 2016
Study Type : Human Study
Additional Links
Substances : Silymarin : CK(455) : AC(112)
Diseases : Anxiety Disorders : CK(1558) : AC(241), Depression, Hepatitis C : CK(773) : AC(163)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Antiviral Agents : CK(3095) : AC(1702)
Additional Keywords : Antioxidants : CK(303) : AC(126), Antiviral Agents, Anxiety Disorders, Depression : CK(108) : AC(19), hepatitis C, SILYMARIN

These results indicate that fasting decrease anxiety-like behaviour and improves memory.

Article Published Date : May 31, 2017
Study Type : Animal Study
Additional Links
Diseases : Anxiety Disorders : CK(1558) : AC(241)
Therapeutic Actions : Fasting/Caloric Restriction : CK(820) : AC(176)
Pharmacological Actions : Anti-Anxiety Agents : CK(4846) : AC(804)
Additional Keywords : Anti-Anxiety Agents, Anxiety Disorders, Fasting/Caloric Restriction

These results suggest that CBD has anxiolytic properties.

Article Published Date : Jan 31, 2004
Study Type : Human Study
Additional Links
Substances : Cannabidiol : CK(3371) : AC(1007)
Diseases : Anxiety Disorders : CK(1558) : AC(241)
Pharmacological Actions : Anti-Anxiety Agents : CK(4846) : AC(804)
Additional Keywords : Anti-Anxiety Agents, Anxiety Disorders, Cannabidiol

Connect with GreenMedInfo